Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
Study on the relation between serum complement (C3, C4) levels and acute exacerbations in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005
Placenta growth factor (PlGF) triggers small airway remodeling (SAR) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017
Expression of epidermal growth factor receptor (EGFR) in the bronchial epithelium of patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population Source: Eur Respir J 2001; 18: 482-490 Year: 2001
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009
Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006
Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012
Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021
Altered expression of TLR4 and of beta 2 defensin in chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 549s Year: 2006
Altered expression of TLR4 and of beta defensin 2 in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 213s Year: 2007
Identification and quantification of NF-kB transcription factor in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 316s Year: 2001
Periostin levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018
Predictive factors of endothelial function in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007
Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001
Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008
Reduced myofibrillar protein breakdown in stable patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004
Serum leptin and tumor necrosis factor – alpha levels and maximal exercise performance in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008